Evaluating a light-activated vascular treatment using human artery models
Supporting development of a novel endovascular technology through ex vivo human tissue studies
Background
Peripheral arterial disease (PAD) is commonly treated using interventional procedures such as balloon angioplasty. However, vessel injury, altered contractility, and local inflammatory responses can contribute to restenosis and limited long‑term efficacy.
Researchers evaluated a light-activated vascular treatment in isolated human popliteal arteries to determine whether the treatment affected normal vascular function. Findings from the study were later discussed in a published interview with the research team.
The Challenge
A key objective of the study was to determine whether treatment with the light-activated compound altered normal constriction and relaxation responses in human blood vessels. We looked to:
- Assess treatment effects directly in human arterial tissue
- Replicate key elements of angioplasty‑like mechanical stress
- Evaluate changes in vascular contractility and compliance
- Generate mechanistic and functional data to inform device development
Conventional cell‑based systems were not sufficient to model the combined mechanical, pharmacological, and light‑activated aspects of the technology.
REPROCELL's Approach
Human popliteal arteries were evaluated using tissue bath methodology following treatment with the light-activated compound and light exposure. Vascular constriction and relaxation responses were subsequently assessed.
All work was conducted at REPROCELL Europe in Glasgow under established tissue handling and experimental SOPs.
Human artery ex vivo model
Tissue selection and handling
- Popliteal artery tissue from human donors was used under appropriate consent and ethical procedures
- Arteries were dissected into segments and prepared for simultaneous testing
- Macroscopically diseased or necrotic tissue was excluded
This ensured functional responses were measured in well‑characterised, viable human vascular tissue.
Treatment and assessment
Human popliteal artery samples were pre-treated with the light-activated compound and exposed to light before functional testing. Researchers then compared vascular responses between treated and control tissues to determine whether the treatment altered normal vessel function.
Functional vascular assessment
Researchers used a tissue bath methodology to evaluate constriction and relaxation responses in treated and untreated artery samples. Exposure to U46619 and sodium nitroprusside allowed the team to determine whether the treatment affected normal vascular function. The study found no significant impact on physiological vessel activity
Inflammatory and molecular readouts
Researchers measured IL-6 levels in cultured artery rings following treatment. Results showed a non-significant reduction in inflammatory cytokine levels in treated samples.
Key outcomes
The study found that treatment did not significantly affect normal vascular constriction or relaxation responses in human arteries. The researchers concluded that the approach appeared safe for use in human blood vessels and reported that clinical evaluation was underway.
The publicly reported findings demonstrated preservation of normal vascular function following treatment in human artery samples. The article also reported that the technology had progressed to clinical testing for patients with symptomatic peripheral artery disease.